Arkolith/Insider Trading/NKTR/Form 4

Wilson Mark Andrew

Chief Legal OfficerNEKTAR THERAPEUTICS (NKTR) · full profile →Form 4 · filed Aug 21, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$18K
Net Open-Market Flow
-$18K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 19, 2025Sell(S)676$26.59$18K20K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 19, 2025Grant(A)22K—$022K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-110774) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML